Clinical Trial Update: Flexitouch Lymphedema System in Treating Stage II Lymphedema in Patients With Breast Cancer [NA]

View source ↗

Summary

The clinical trial update indicates that the Flexitouch Lymphedema System trial for stage II lymphedema in breast cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphedema

Drugs mentioned

• Flexitouch Lymphedema System

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Breast Cancer, Lymphedema | NA | Status: TERMINATED